Alison K. Kearns, Ph.D. - Publications

2013 Biomedical Sciences University of Montana, Missoula, MT 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Weaver MJ, Kearns AK, Stump S, Li C, Gajewski MP, Rider KC, Backos DS, Reigan PR, Beall HD, Natale NR. AIMing towards improved antitumor efficacy. Bioorganic & Medicinal Chemistry Letters. 25: 1765-70. PMID 25782743 DOI: 10.1016/J.Bmcl.2015.02.063  0.613
2014 Duncan NS, Beall HD, Kearns AK, Li C, Natale NR. Ethyl 3-(9-chloro-10-oxo-9,10-di-hydro-anthracen-9-yl)-5-methyl-isoxazole-4-carboxyl-ate. Acta Crystallographica. Section E, Structure Reports Online. 70: o315-6. PMID 24765016 DOI: 10.1107/S1600536814003080  0.566
2013 Keyari CM, Kearns AK, Duncan NS, Eickholt EA, Abbott G, Beall HD, Diaz P. Synthesis of new quinolinequinone derivatives and preliminary exploration of their cytotoxic properties. Journal of Medicinal Chemistry. 56: 3806-19. PMID 23574193 DOI: 10.1021/Jm301689X  0.597
2012 Mirzaei YR, Weaver MJ, Steiger SA, Kearns AK, Gajewski MP, Rider KC, Beall HD, Natale NR. Improved synthesis of 3-aryl isoxazoles containing fused aromatic rings. Tetrahedron. 68: 10360-10364. PMID 23526841 DOI: 10.1016/J.Tet.2012.09.084  0.571
2012 Kearns AK, Gajewski MP, Natale NR, Beall HD. Abstract 1767: Anthracenyl isoxazole amides (AIMs) as novel agents for brain tumors Cancer Research. 72: 1767-1767. DOI: 10.1158/1538-7445.Am2012-1767  0.612
Show low-probability matches.